Drugmakers keen on expanded coverage of DMF system

Published: 2010-09-10 07:00:00

Updated: 2010-09-10 07:00:00

The Korea Food and Drug Administration is considering providing assistance to industry, in particular Active Pharmaceutical Ingredient (API) manufacturers, on the requirements of drug substance as the drug agency intends to formulate the guideline aiming to expand the current scope of drug master...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK